EICHORCondition: COPD · Sponsor: Temple University
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks.
This description comes directly from the study's public registry record.
Gerard Criner, MD · 215-707-8113 · Gerard.Criner@tuhs.temple.edu
Stephanie Yerkes · 215-707-2357 · stephanie.yerkes@temple.edu
Always discuss trial participation with your own doctor first.
| UAB School of Medicine/Lung Health Center | Birmingham, Alabama, United States | Recruiting |
| Honor Health | Scottsdale, Arizona, United States | Recruiting |
| University of Florida, Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Alloy Clinical Research | Kissimmee, Florida, United States | Recruiting |
| Reliable Research, Inc. | Miami, Florida, United States | Recruiting |
| NewGen Health Group | Miami, Florida, United States | Recruiting |
| Destiny Research | Palmetto Bay, Florida, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| The Iowa Clinic | West Des Moines, Iowa, United States | Recruiting |
| University of Maryland - Baltimore | Baltimore, Maryland, United States | Recruiting |
| Tufts Medical Center | Boston, Massachusetts, United States | Recruiting |
| Lahey Hospital and Medical Center | Burlington, Massachusetts, United States | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05204888